Document And Entity Information
Document And Entity Information - shares | 9 Months Ended | |
Nov. 30, 2021 | Jan. 03, 2022 | |
Document Information Line Items | ||
Entity Registrant Name | EDUCATIONAL DEVELOPMENT CORPORATION | |
Trading Symbol | EDUC | |
Document Type | 10-Q | |
Current Fiscal Year End Date | --02-28 | |
Entity Common Stock, Shares Outstanding | 8,707,247 | |
Amendment Flag | false | |
Entity Central Index Key | 0000031667 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Accelerated Filer | |
Document Period End Date | Nov. 30, 2021 | |
Document Fiscal Year Focus | 2022 | |
Document Fiscal Period Focus | Q3 | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity File Number | 000-04957 | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 73-0750007 | |
Entity Address, Address Line One | 5402 South 122nd East Ave | |
Entity Address, City or Town | Tulsa | |
Entity Address, State or Province | OK | |
Entity Address, Postal Zip Code | 74146 | |
City Area Code | 918 | |
Local Phone Number | 622-4522 | |
Title of 12(b) Security | Common Stock, $.20 par value | |
Security Exchange Name | NASDAQ | |
Entity Interactive Data Current | Yes |
CONDENSED BALANCE SHEETS
CONDENSED BALANCE SHEETS - USD ($) | Nov. 30, 2021 | Feb. 28, 2021 |
CURRENT ASSETS | ||
Cash and cash equivalents | $ 906,700 | $ 1,812,200 |
Accounts receivable, less allowance for doubtful accounts of $315,600 (November 30) and $331,900 (February 28) | 4,731,600 | 3,346,700 |
Inventories - net | 69,236,200 | 51,762,400 |
Prepaid expenses and other assets | 1,203,800 | 1,219,300 |
Total current assets | 76,078,300 | 58,140,600 |
INVENTORIES - net | 1,848,500 | 685,300 |
PROPERTY, PLANT AND EQUIPMENT - net | 30,758,100 | 29,951,000 |
DEFERRED INCOME TAX ASSET | 136,800 | 0 |
OTHER ASSETS | 248,100 | 73,600 |
TOTAL ASSETS | 109,069,800 | 88,850,500 |
CURRENT LIABILITIES | ||
Accounts payable | 23,064,500 | 19,674,300 |
Line of credit | 3,019,400 | 5,245,300 |
Deferred revenues | 1,155,700 | 2,475,900 |
Current maturities of long-term debt | 2,525,400 | 533,500 |
Accrued salaries and commissions | 3,559,500 | 3,488,000 |
Dividends payable | 865,600 | 835,100 |
Income taxes payable | 584,100 | 130,200 |
Other current liabilities | 4,478,700 | 5,533,000 |
Total current liabilities | 39,252,900 | 37,915,300 |
LONG-TERM DEBT - net | 22,952,900 | 10,451,200 |
DEFERRED INCOME TAX LIABILITY | 0 | 89,900 |
OTHER LONG-TERM LIABILITIES | 276,000 | 134,300 |
Total liabilities | 62,481,800 | 48,590,700 |
SHAREHOLDERS' EQUITY | ||
Common stock, $0.20 par value; Authorized 16,000,000 shares; Issued 12,702,080 (November 30) and 12,410,080 (February 28) shares; Outstanding 8,656,135 (November 30) and 8,346,600 (February 28) shares | 2,540,400 | 2,482,000 |
Capital in excess of par value | 11,683,000 | 10,863,900 |
Retained earnings | 45,071,900 | 39,683,000 |
59,295,300 | 53,028,900 | |
Less treasury stock, at cost | (12,707,300) | (12,769,100) |
Total shareholders' equity | 46,588,000 | 40,259,800 |
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $ 109,069,800 | $ 88,850,500 |
CONDENSED BALANCE SHEETS (Paren
CONDENSED BALANCE SHEETS (Parentheticals) - USD ($) | Nov. 30, 2021 | Feb. 28, 2021 |
Statement of Financial Position [Abstract] | ||
Accounts receivable, allowance for doubtful accounts (in Dollars) | $ 315,600 | $ 331,900 |
Common stock, shares issued | 12,702,080 | 12,410,080 |
Common stock, authorized shares | 16,000,000 | 16,000,000 |
Common stock, par value (in Dollars per share) | $ 0.2 | $ 0.2 |
Common stock, shares outstanding | 8,656,135 | 8,346,600 |
CONDENSED STATEMENTS OF EARNING
CONDENSED STATEMENTS OF EARNINGS - USD ($) | 3 Months Ended | 9 Months Ended | ||
Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2021 | Nov. 30, 2020 | |
NET REVENUES | $ 45,112,300 | $ 66,750,300 | $ 118,914,600 | $ 164,292,100 |
COST OF GOODS SOLD | 13,897,300 | 19,597,800 | 36,426,000 | 48,302,800 |
Gross margin | 31,215,000 | 47,152,500 | 82,488,600 | 115,989,300 |
OPERATING EXPENSES | ||||
Operating and selling | 7,354,500 | 11,616,200 | 19,037,000 | 28,488,300 |
Sales commissions | 14,515,500 | 22,960,300 | 37,587,400 | 56,865,200 |
General and administrative | 5,915,000 | 7,082,200 | 15,847,900 | 17,282,200 |
Total operating expenses | 27,785,000 | 41,658,700 | 72,472,300 | 102,635,700 |
INTEREST EXPENSE | 228,300 | 119,300 | 609,800 | 441,500 |
OTHER INCOME | (400,900) | (399,800) | (1,514,800) | (1,305,600) |
EARNINGS BEFORE INCOME TAXES | 3,602,600 | 5,774,300 | 10,921,300 | 14,217,700 |
INCOME TAXES | 956,000 | 1,504,700 | 2,938,400 | 3,762,000 |
NET EARNINGS | $ 2,646,600 | $ 4,269,600 | $ 7,982,900 | $ 10,455,700 |
BASIC AND DILUTED EARNINGS PER SHARE | ||||
Basic (in Dollars per share) | $ 0.33 | $ 0.51 | $ 0.99 | $ 1.25 |
Diluted (in Dollars per share) | $ 0.31 | $ 0.51 | $ 0.94 | $ 1.25 |
WEIGHTED AVERAGE NUMBER OF COMMON AND EQUIVALENT SHARES OUTSTANDING | ||||
Basic (in Shares) | 8,029,060 | 8,355,831 | 8,028,973 | 8,354,156 |
Diluted (in Shares) | 8,430,221 | 8,355,831 | 8,449,183 | 8,354,156 |
Dividends per share (in Dollars per share) | $ 0.1 | $ 0.1 | $ 0.3 | $ 0.22 |
Gross Sales [Member] | ||||
REVENUES | $ 58,032,800 | $ 83,137,500 | $ 154,611,500 | $ 203,717,200 |
Discounts and Allowances [Member] | ||||
WEIGHTED AVERAGE NUMBER OF COMMON AND EQUIVALENT SHARES OUTSTANDING | ||||
Less discounts and allowances | (16,978,600) | (24,131,100) | (47,446,200) | (58,390,400) |
Transportation Revenue [Member] | ||||
REVENUES | $ 4,058,100 | $ 7,743,900 | $ 11,749,300 | $ 18,965,300 |
CONDENSED STATEMENTS OF SHAREHO
CONDENSED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Treasury Stock [Member] | Total |
Balance at Feb. 29, 2020 | $ 2,482,000 | $ 9,843,900 | $ 29,732,200 | $ (12,665,300) | $ 29,392,800 |
Balance (in Shares) at Feb. 29, 2020 | 12,410,080 | 4,061,429 | |||
Purchases of treasury stock | $ (75,500) | (75,500) | |||
Purchases of treasury stock (in Shares) | 17,565 | ||||
Sales of treasury stock | 5,000 | $ 66,000 | 71,000 | ||
Sales of treasury stock (in Shares) | (21,167) | ||||
Dividends declared | (502,200) | (502,200) | |||
Share-based compensation expense (see Note 6) | 169,000 | 169,000 | |||
Net earnings | 1,931,100 | 1,931,100 | |||
Balance at May. 31, 2020 | $ 2,482,000 | 10,017,900 | 31,161,100 | $ (12,674,800) | 30,986,200 |
Balance (in Shares) at May. 31, 2020 | 12,410,080 | 4,057,827 | |||
Balance at Feb. 29, 2020 | $ 2,482,000 | 9,843,900 | 29,732,200 | $ (12,665,300) | 29,392,800 |
Balance (in Shares) at Feb. 29, 2020 | 12,410,080 | 4,061,429 | |||
Net earnings | 10,455,700 | ||||
Balance at Nov. 30, 2020 | $ 2,482,000 | 10,552,600 | 38,349,900 | $ (12,663,200) | 38,721,300 |
Balance (in Shares) at Nov. 30, 2020 | 12,410,080 | 4,054,108 | |||
Balance at May. 31, 2020 | $ 2,482,000 | 10,017,900 | 31,161,100 | $ (12,674,800) | 30,986,200 |
Balance (in Shares) at May. 31, 2020 | 12,410,080 | 4,057,827 | |||
Sales of treasury stock | 11,500 | $ 7,600 | 19,100 | ||
Sales of treasury stock (in Shares) | (2,438) | ||||
Dividends declared | (500,300) | (500,300) | |||
Share-based compensation expense (see Note 6) | 216,200 | 216,200 | |||
Net earnings | 4,255,000 | 4,255,000 | |||
Balance at Aug. 31, 2020 | $ 2,482,000 | 10,245,600 | 34,915,800 | $ (12,667,200) | 34,976,200 |
Balance (in Shares) at Aug. 31, 2020 | 12,410,080 | 4,055,389 | |||
Sales of treasury stock | 15,200 | $ 4,000 | 19,200 | ||
Sales of treasury stock (in Shares) | (1,281) | ||||
Dividends declared | (835,500) | (835,500) | |||
Share-based compensation expense (see Note 6) | 291,800 | 291,800 | |||
Net earnings | 4,269,600 | 4,269,600 | |||
Balance at Nov. 30, 2020 | $ 2,482,000 | 10,552,600 | 38,349,900 | $ (12,663,200) | 38,721,300 |
Balance (in Shares) at Nov. 30, 2020 | 12,410,080 | 4,054,108 | |||
Balance at Feb. 28, 2021 | $ 2,482,000 | 10,863,900 | 39,683,000 | $ (12,769,100) | 40,259,800 |
Balance (in Shares) at Feb. 28, 2021 | 12,410,080 | 4,063,480 | |||
Sales of treasury stock | 26,600 | $ 5,400 | 32,000 | ||
Sales of treasury stock (in Shares) | (1,714) | ||||
Dividends declared | (834,800) | (834,800) | |||
Share-based compensation expense (see Note 6) | 261,600 | 261,600 | |||
Net earnings | 3,438,100 | 3,438,100 | |||
Balance at May. 31, 2021 | $ 2,482,000 | 11,152,100 | 42,286,300 | $ (12,763,700) | 43,156,700 |
Balance (in Shares) at May. 31, 2021 | 12,410,080 | 4,061,766 | |||
Balance at Feb. 28, 2021 | $ 2,482,000 | 10,863,900 | 39,683,000 | $ (12,769,100) | 40,259,800 |
Balance (in Shares) at Feb. 28, 2021 | 12,410,080 | 4,063,480 | |||
Net earnings | 7,982,900 | ||||
Balance at Nov. 30, 2021 | $ 2,540,400 | 11,683,000 | 45,071,900 | $ (12,707,300) | 46,588,000 |
Balance (in Shares) at Nov. 30, 2021 | 12,702,080 | 4,045,945 | |||
Balance at May. 31, 2021 | $ 2,482,000 | 11,152,100 | 42,286,300 | $ (12,763,700) | 43,156,700 |
Balance (in Shares) at May. 31, 2021 | 12,410,080 | 4,061,766 | |||
Sales of treasury stock | 46,100 | $ 14,300 | 60,400 | ||
Sales of treasury stock (in Shares) | (4,915) | ||||
Issuance of restricted share awards for vesting | $ 58,400 | (82,000) | $ 23,600 | ||
Issuance of restricted share awards for vesting (in Shares) | 292,000 | (5,000) | |||
Dividends declared | (893,600) | (893,600) | |||
Share-based compensation expense (see Note 6) | 261,700 | 261,700 | |||
Net earnings | 1,898,200 | 1,898,200 | |||
Balance at Aug. 31, 2021 | $ 2,540,400 | 11,377,900 | 43,290,900 | $ (12,725,800) | 44,483,400 |
Balance (in Shares) at Aug. 31, 2021 | 12,702,080 | 4,051,851 | |||
Sales of treasury stock | 43,500 | $ 18,500 | 62,000 | ||
Sales of treasury stock (in Shares) | (5,906) | ||||
Dividends declared | (865,600) | (865,600) | |||
Share-based compensation expense (see Note 6) | 261,600 | 261,600 | |||
Net earnings | 2,646,600 | 2,646,600 | |||
Balance at Nov. 30, 2021 | $ 2,540,400 | $ 11,683,000 | $ 45,071,900 | $ (12,707,300) | $ 46,588,000 |
Balance (in Shares) at Nov. 30, 2021 | 12,702,080 | 4,045,945 |
CONDENSED STATEMENTS OF SHARE_2
CONDENSED STATEMENTS OF SHAREHOLDERS' EQUITY (Parentheticals) - $ / shares | 3 Months Ended | |||||
Nov. 30, 2021 | Aug. 31, 2021 | May 31, 2021 | Nov. 30, 2020 | Aug. 31, 2020 | May 31, 2020 | |
Retained Earnings [Member] | ||||||
Dividends declared | $ 0.1 | $ 0.1 | $ 0.1 | $ 0.1 | $ 0.06 | $ 0.06 |
CONDENSED STATEMENTS OF CASH FL
CONDENSED STATEMENTS OF CASH FLOWS - USD ($) | 9 Months Ended | |
Nov. 30, 2021 | Nov. 30, 2020 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||
Net earnings | $ 7,982,900 | $ 10,455,700 |
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities: | ||
Depreciation | 1,518,700 | 1,207,900 |
Deferred income taxes | (226,700) | (809,800) |
Provision for doubtful accounts | 91,800 | 115,800 |
Provision for inventory valuation allowance | 180,000 | 166,200 |
Share-based compensation expense | 784,900 | 677,000 |
Changes in assets and liabilities: | ||
Accounts receivable | (1,476,700) | (1,264,200) |
Inventories, net | (18,817,000) | (17,130,200) |
Prepaid expenses and other assets | (159,000) | (239,200) |
Accounts payable | 4,451,400 | 35,498,700 |
Accrued salaries and commissions and other liabilities | (841,100) | 8,598,200 |
Deferred revenues | (1,320,200) | 2,128,400 |
Income taxes payable | 453,900 | 213,300 |
Total adjustments | (15,360,000) | 29,162,100 |
Net cash provided by (used in) operating activities | (7,377,100) | 39,617,800 |
CASH FLOWS FROM INVESTING ACTIVITIES | ||
Purchases of property, plant and equipment | (3,387,100) | (2,040,000) |
Net cash used in investing activities | (3,387,100) | (2,040,000) |
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Payments on term debt | (751,100) | (9,144,300) |
Proceeds from term debt | 15,244,700 | 1,447,400 |
Sales of treasury stock | 154,400 | 109,300 |
Purchases of treasury stock | 0 | (75,500) |
Net payments on line of credit | (2,225,900) | 0 |
Dividends paid | (2,563,400) | (1,419,800) |
Net cash provided by (used in) financing activities | 9,858,700 | (9,082,900) |
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | (905,500) | 28,494,900 |
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD | 1,812,200 | 2,999,400 |
CASH AND CASH EQUIVALENTS - END OF PERIOD | 906,700 | 31,494,300 |
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION | ||
Cash paid for interest | 606,300 | 463,600 |
Cash paid for income taxes | $ 2,708,000 | $ 3,789,500 |
BASIS OF PRESENTATION AND SUMMA
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 9 Months Ended |
Nov. 30, 2021 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies [Text Block] | Note 1 Basis of Presentation The accompanying Unaudited Condensed Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim condensed financial information and in accordance with the rules and regulations of the Securities and Exchange Commission. The Unaudited Condensed Financial Statements include all adjustments considered necessary for a fair presentation of the financial position and results of operations for the interim periods presented. Such adjustments consist only of normal recurring items, unless otherwise disclosed herein. Accordingly, the Unaudited Condensed Financial Statements do not include all of the information and notes required by GAAP for complete financial statements. However, we believe that the disclosures made are adequate to make the information not misleading. These interim Unaudited Condensed Financial Statements should be read in conjunction with our audited financial statements as of and for the year ended February 28, 2021 included in our Form 10-K. The results of operations for interim periods are not necessarily indicative of the results to be expected for a full year due to the seasonality of our product sales. Reclassifications Certain reclassifications have been made to the fiscal 2021 condensed balance sheet, condensed statement of cash flows and footnotes to conform to the classifications used in fiscal 2022. These reclassifications had no effect on net earnings. COVID-19 Update The Company has taken numerous steps, and will continue to take further actions, in its approach to minimize the impact of the COVID-19 pandemic. Effective May 1, 2021, we lessened our safety and health practices in the office and warehouse based on the recommendations from the local Tulsa Health Department. We are closely monitoring the impact of the COVID-19 pandemic and continually assessing its potential effects on our business. While the Company did not experience a decrease in net revenues during fiscal year 2021, and the year-to-date results of fiscal 2022 are more normalized, the long-term severity and duration of the pandemic are uncertain and the extent to which our results are affected by COVID-19 cannot be accurately predicted. See Management’s Discussion and Analysis of Financial Condition and Results of Operations for more information on the impact COVID-19 had during the current fiscal period. Use of Estimates in the Preparation of Financial Statements The preparation of the Unaudited Condensed Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in these financial statements and accompanying notes. Actual results could differ from those estimates. Significant Accounting Policies Our significant accounting policies, other than the adoption of new accounting pronouncements separately documented herein, are consistent with those disclosed in Note 1 to our audited financial statements as of and for the year ended February 28, 2021 included in our Form 10-K. New Accounting Pronouncements The Financial Accounting Standards Board (“FASB”) periodically issues new accounting standards in a continuing effort to improve standards of financial accounting and reporting. We have reviewed the recently issued accounting standards updates (“ASU”) and concluded that the following recently issued accounting standards apply to us: In December 2019, the FASB published ASU 2019-12: Income Taxes (Topic 740), which simplifies the accounting for income taxes. Topic 740 addresses a number of topics including but not limited to the removal of certain exceptions currently included in the standard related to intra-period allocation when there are losses, in addition to calculation of income taxes when current year-to-date losses exceed anticipated loss for the year. The amendment also simplifies accounting for certain franchise taxes and disclosure of the effect of enacted change in tax laws or rates. Topic 740 was adopted by the Company at the beginning of fiscal year 2022 and did not have a material impact on our financial statements and disclosures. In March 2020, the FASB issued ASU 2020-04: Reference Rate Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This update provides optional guidance for a limited period of time to ease potential accounting impacts associated with transitioning away from reference rates that are expected to be discontinued, such as London Interbank Offered Rate (LIBOR). This ASU includes practical expedients for contract modifications due to reference rate reform. Generally, contract modifications related to reference rate reform may be considered an event that does not require remeasurement or reassessment of a previous accounting determination at the modification date. This ASU is effective March 12, 2020 through December 31, 2022. The Company’s debt agreements include the use of alternate rates when LIBOR is not available. We do not expect the change from LIBOR to an alternate rate will have a material impact to our financial statements and, to the extent we enter into modifications of agreements that are impacted by the LIBOR phase-out, we will apply such guidance to those contract modifications. |
INVENTORIES
INVENTORIES | 9 Months Ended |
Nov. 30, 2021 | |
Inventory Disclosure [Abstract] | |
Inventory Disclosure [Text Block] | Note 2 Inventories consist of the following: November 30, 2021 February 28, 2021 Current: Book inventory $ 69,851,400 $ 52,276,200 Inventory valuation allowance (615,200 ) (513,800 ) Inventories net – current $ 69,236,200 $ 51,762,400 Noncurrent: Book inventory $ 2,165,500 $ 894,300 Inventory valuation allowance (317,000 ) (209,000 ) Inventories net – noncurrent $ 1,848,500 $ 685,300 Book inventory includes inventory in transit which totaled $4,204,700 and $6,467,400 at November 30, 2021 and February 28, 2021, respectively. Book inventory quantities in excess of what we expect will be sold within the normal operating cycle, based on 2½ years of anticipated sales, are included in noncurrent inventory. Significant portions of our inventory purchases are concentrated with an England-based publishing company, Usborne Publishing, Ltd. (“Usborne”). Purchases received from this company were $10,728,800 and $26,199,600 for the three months ended November 30, 2021 and 2020, respectively. Total inventory purchases received from all suppliers were $15,946,700 and $34,973,000 for the three months ended November 30, 2021 and 2020, respectively. Purchases received from Usborne were $35,144,100 and $37,531,600 for the nine months ended November 30, 2021 and 2020, respectively. Total inventory purchases received from all suppliers were $52,511,000 and $53,190,200 for the nine months ended November 30, 2021 and 2020, respectively. |
LEASES
LEASES | 9 Months Ended |
Nov. 30, 2021 | |
Disclosure Text Block [Abstract] | |
Lessor, Operating Leases [Text Block] | Note 3 We have both lessee and lessor arrangements. Our leases are evaluated at inception or at any subsequent modification. Depending on the terms, leases are classified as either operating or finance leases if we are the lessee, or as operating, sales-type or direct financing leases if we are the lessor, as appropriate under ASC 842. One lessee arrangement includes a rental agreement where we have the exclusive use of dedicated office space in San Diego, California, and qualifies as an operating lease. Our other lessee arrangement is short-term and offers flexible storage space on a month-to-month basis. Our lessee arrangements are not material to our condensed financial statements or notes to the condensed financial statements. Our lessor arrangements include three rental agreements for warehouse and office space in Tulsa, Oklahoma, and each qualifies as an operating lease under ASC 842. Operating Leases Lessor We recognize fixed rental income on a straight-line basis over the life of the lease as other income on our condensed statements of earnings. Variable rental payments are recognized as other income in the period in which the changes in facts and circumstances on which the variable lease payments are based occur. On April 4, 2020, we executed an amendment to one of our existing leases that abated rental payments for the months of May, June and July 2020. The amendment also extended the term of the lease for three additional months. This amendment represents a lease modification and, as such, we have adjusted our fixed rental income on a straight-line basis over the remaining term starting May 1, 2020. Future minimum payments receivable under operating leases with terms greater than one year are estimated as follows: Years ending February 28 (29), 2022 $ 391,100 2023 1,573,200 2024 1,577,900 2025 1,547,100 2026 1,524,300 Thereafter 8,091,000 Total $ 14,704,600 The cost of the leased space was $10,834,300 and $10,826,400 as of November 30, 2021 and February 28, 2021, respectively. The accumulated depreciation associated with the leased assets was $2,506,600 and $2,216,700 as of November 30, 2021 and February 28, 2021, respectively. Both the leased assets and accumulated depreciation are included in property, plant and equipment-net on the condensed balance sheets. |
DEBT
DEBT | 9 Months Ended |
Nov. 30, 2021 | |
Debt Disclosure [Abstract] | |
Debt Disclosure [Text Block] | Note 4 Debt consists of the following: November 30, 2021 February 28, 2021 Line of credit $ 3,019,400 $ 5,245,300 Advancing term loan #1 $ 5,013,700 $ - Advancing term loan #2 10,000,000 - Term loan #1 10,514,200 10,984,700 Total long-term debt 25,527,900 10,984,700 Less current maturities (2,525,400 ) (533,500 ) Less debt issue cost (49,600 ) - Long-term debt, net $ 22,952,900 $ 10,451,200 The Company executed an Amended and Restated Loan Agreement on February 15, 2021 (as amended the “Loan Agreement”) with MidFirst Bank (“the Bank”), which replaced the prior loan agreement and includes multiple loans. Term Loan #1 Tranche A (“Term Loan #1”), originally totaling $13.4 million, was part of the prior loan agreement. Term Loan #1 had a fixed interest rate of 4.23% with principal and interest payable monthly and a stated maturity date of December 1, 2025. On April 1, 2021, the Company executed the First Amendment to the Loan Agreement which reduced the fixed interest rate on Term Loan #1 to 3.12% and removed the prepayment premium from the Loan Agreement. Term Loan #1 is secured by the primary office, warehouse and land. The Loan Agreement also provides a $20.0 million revolving loan (“line of credit”) through August 15, 2022 with interest payable monthly at the Bank-adjusted LIBOR Index plus a tiered pricing rate based on the Company’s Adjusted Funded Debt to EBITDA Ratio, with a minimum rate of 3.00% (the effective rate was 3.00% at November 30, 2021). On July 16, 2021, the Company executed the Second Amendment to the Loan Agreement which increased the Maximum Revolving Principal Amount from $15.0 million to $20.0 million. On August 31, 2021, the Company executed the Third Amendment to the Loan Agreement which modified the advance rates used in the borrowing base certificate. Available credit under the revolving line of credit was approximately $16,980,600 and $9,570,200 at November 30, 2021 and February 28, 2021, respectively. In addition, the Loan Agreement provides a $6.0 million Advancing Term Loan #1 to be used to finance planned equipment purchases. The Advancing Term Loan #1 required interest-only payments through July 15, 2021, at which time it was converted to a 60-month amortizing term loan maturing July 15, 2026. The Advancing Term Loan #1 accrues interest at the Bank-adjusted LIBOR Index plus a tiered pricing rate based on the Company’s Adjusted Funded Debt to EBITDA Ratio, with a minimum rate of 3.00% (the effective rate was 3.00% at November 30, 2021). On November 19, 2021, the Company executed the Fourth Amendment to the Loan Agreement which established Advancing Term Loan #2 in the principal amount of $10.0 million, amended the definition of LIBO Rate and LIBOR Margin and added Benchmark Replacement Provisions. The Advancing Term Loan #2 is a 120-month amortizing loan maturing November 19, 2031 and accrues interest at the Bank-adjusted LIBOR Index plus a tiered pricing rate based on the Company’s Adjusted Funded Debt to EBITDA Ratio, with a minimum rate of 3.00% (the effective rate was 3.00% at November 30, 2021). Adjusted Funded Debt is defined as all long-term and short-term bank debt less the outstanding balance of Term Loan #1. EBITDA is defined in the Loan Agreement as net income plus interest expense, income tax expense (benefit) and depreciation and amortization expenses. The Adjusted Funded Debt to EBITDA ratio includes Adjusted Funded Debt to trailing twelve months EBITDA, reduced by specific rental income received from a non-related third party, see Note 3. The $20.0 million line of credit is limited to advance rates on eligible receivables and eligible inventory levels. The advancing term loans and the line of credit accrue interest at a tiered rate based on our Adjusted Funded Debt to EBITDA ratio. The variable interest pricing tiers are as follows: Pricing Tier Adjusted Funded Debt to EBITDA Ratio LIBOR Margin (bps) I > 2.50 325.00 II > 2.00 but < 300.00 III > 1.50 but < 275.00 IV < 250.00 The Loan Agreement contains a provision for our use of the Bank’s letters of credit. The Bank agrees to issue or obtain issuance of commercial or stand-by letters of credit provided that no letters of credit will have an expiry date later than August 15, 2022, and that the sum of the line of credit plus the letters of credit would not exceed the borrowing base in effect at the time. As of November 30, 2021, we had no letters of credit outstanding. The Loan Agreement also contains provisions that require the Company to maintain specified financial ratios and limits any additional debt with other lenders. Additionally, the Loan Agreement places limitations on the amount of dividends that may be distributed and the total value of stock that can be repurchased using advances from the line of credit. The following table reflects aggregate future scheduled maturities of long-term debt during the next five fiscal years and thereafter as follows: Years ending February 28 (29), 2022 $ 622,700 2023 2,541,800 2024 2,587,900 2025 2,634,700 2026 10,499,200 Thereafter 6,641,600 Total $ 25,527,900 |
EARNINGS PER SHARE
EARNINGS PER SHARE | 9 Months Ended |
Nov. 30, 2021 | |
Earnings Per Share [Abstract] | |
Earnings Per Share [Text Block] | Note 5 Basic earnings per share (“EPS”) is computed by dividing net earnings by the weighted average number of common shares outstanding during the period excluding nonvested restricted stock awards. Diluted EPS includes the dilutive effect of issued unvested restricted stock awards and additional potential common shares issuable under stock warrants, restricted stock and stock options. We utilized the treasury stock method in computing the potential common shares issuable under stock warrants, restricted stock and stock options. The computation of weighted average common and common equivalent shares used in the calculation of basic and diluted EPS is shown below: Three Months Ended November 30, Nine Months Ended November 30, 2021 2020 2021 2020 Earnings: Net earnings applicable to common shareholders $ 2,646,600 $ 4,269,600 $ 7,982,900 $ 10,455,700 Weighted average shares: Weighted average shares outstanding-basic 8,029,060 8,355,831 8,028,973 8,354,156 Issued unvested restricted stock and assumed shares issuable under granted unvested restricted stock awards 401,161 - 420,210 - Weighted average shares outstanding-diluted 8,430,221 8,355,831 8,449,183 8,354,156 Earnings per share: Basic $ 0.33 $ 0.51 $ 0.99 $ 1.25 Diluted $ 0.31 $ 0.51 $ 0.94 $ 1.25 |
STOCK-BASED COMPENSATION
STOCK-BASED COMPENSATION | 9 Months Ended |
Nov. 30, 2021 | |
Share-based Payment Arrangement, Disclosure [Abstract] | |
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block] | Note 6 We account for share-based compensation whereby share-based payment transactions with employees, such as stock options and restricted stock, are measured at estimated fair value at the date of grant. For awards subject to service conditions, compensation expense is recognized over the vesting period on a straight-line basis. Awards subject to performance conditions are attributed separately for each vesting tranche of the award and are recognized ratably from the service inception date to the vesting date for each tranche. Forfeitures are recognized when they occur. The probability of restricted share awards granted with future performance conditions is evaluated at each reporting period and share awards are updated and compensation expense is adjusted based on updated information. In July 2018, our shareholders approved the Company’s 2019 Long-Term Incentive Plan (“2019 LTI Plan”). The 2019 LTI Plan established up to 600,000 shares of restricted stock available to be granted to certain members of management based on exceeding specified net revenues and pre-tax performance metrics during fiscal years 2019, 2020 or 2021. The Company exceeded all defined metrics during these fiscal years and 600,000 shares were granted to members of management according to the Plan. The granted shares under the 2019 LTI Plan “cliff vest” after five years from the fiscal year that the defined metrics were exceeded. In July 2021, our shareholders approved the Company’s 2022 Long-Term Incentive Plan (“2022 LTI Plan”). The 2022 LTI Plan establishes up to 300,000 shares of restricted stock available to be granted to certain members of management based on exceeding specified net revenues and pre-tax performance metrics during fiscal years 2022 and 2023. The number of restricted shares to be distributed depends on attaining the performance metrics defined by the 2022 LTI Plan and may result in the distribution of a number of shares that is less than, but not greater than, the number of restricted shares outlined in the terms of the 2022 LTI Plan. Restricted shares granted under the 2022 LTI Plan “cliff vest” after five years from the fiscal year that the defined metrics were exceeded. During fiscal year 2019, the Company granted 308,000 restricted shares under the 2019 LTI Plan with an average grant-date fair value of $9.94 per share. In the third quarter of fiscal year 2021, 5,000 of these restricted shares were forfeited. These shares were made available to be reissued to remaining participants upon forfeiture. The remaining compensation expense for the outstanding awards, totaling approximately $816,900, will be recognized ratably over the remaining vesting period of approximately 15 months. During fiscal year 2021, the Company granted 297,000 restricted shares under the 2019 LTI Plan, including the 5,000 aforementioned shares that were previously forfeited and held in Treasury, with an average grant-date fair value of $6.30 per share. The remaining compensation expense of these awards, totaling approximately $1,276,600, will be recognized ratably over the remaining vesting period of approximately 39 months. As of November 30, 2021, no shares have been granted under the 2022 LTI Plan. A summary of compensation expense recognized in connection with restricted share awards follows: Three Months Ended November 30, Nine Months Ended November 30, 2021 2020 2021 2020 Share-based compensation expense $ 261,600 $ 291,800 $ 784,900 $ 677,000 The following table summarizes stock award activity during the first nine months of fiscal year 2022 under the 2019 LTI Plan: Shares Weighted Average Fair Value (per share) Outstanding at February 28, 2021 600,000 $ 8.14 Granted - - Vested - - Forfeited - - Outstanding at November 30, 2021 600,000 $ 8.14 As of November 30, 2021, total unrecognized share-based compensation expense related to unvested granted or issued restricted shares was $2,093,500, which we expect to recognize over a weighted-average period of 29.6 months. |
SHIPPING AND HANDLING COSTS
SHIPPING AND HANDLING COSTS | 9 Months Ended |
Nov. 30, 2021 | |
Other Income and Expenses [Abstract] | |
Other Operating Income and Expense [Text Block] | Note 7 We classify shipping and handling costs as operating and selling expenses in the condensed statements of earnings. Shipping and handling costs include postage, freight, handling costs, as well as shipping materials and supplies. These costs were $6,924,800 and $10,610,900 for the three months ended November 30, 2021 and 2020, respectively. These costs were $18,317,200 and $26,910,800 for the nine months ended November 30, 2021 and 2020, respectively. |
BUSINESS SEGMENTS
BUSINESS SEGMENTS | 9 Months Ended |
Nov. 30, 2021 | |
Segment Reporting [Abstract] | |
Segment Reporting Disclosure [Text Block] | Note 8 We have two reportable segments: Usborne Books & More (“UBAM”) and Publishing. These reportable segments are business units that offer different methods of distribution to different types of customers. They are managed separately based on the fundamental differences in their operations. Our UBAM segment markets its products through a network of independent sales consultants using a combination of internet sales, direct sales, home shows and book fairs. Our Publishing segment markets its products to retail accounts, which include book, school supply, toy and gift stores and museums, trade and specialty wholesalers, through commissioned sales representatives and our internal tele-sales group. The accounting policies of the segments are the same as those of the rest of the Company. We evaluate segment performance based on earnings before income taxes of the segments, which is defined as segment net revenues reduced by cost of sales and direct expenses. Corporate expenses, depreciation, interest expense and income taxes are not allocated to the segments but are listed in the “Other” row below. Corporate expenses include the executive department, accounting department, information services department, general office management, warehouse operations and building facilities management. Our assets and liabilities are not allocated on a segment basis. Information by reporting segment for the three and nine-month periods ended November 30, 2021 and 2020, are as follows: NET REVENUES Three Months Ended November 30, Nine Months Ended November 30, 2021 2020 2021 2020 UBAM $ 41,397,800 $ 64,169,700 $ 108,532,800 $ 158,007,500 Publishing 3,714,500 2,580,600 10,381,800 6,284,600 Total $ 45,112,300 $ 66,750,300 $ 118,914,600 $ 164,292,100 EARNINGS (LOSS) BEFORE INCOME TAXES Three Months Ended November 30, Nine Months Ended November 30, 2021 2020 2021 2020 UBAM $ 7,536,000 $ 10,821,600 $ 20,976,400 $ 26,311,300 Publishing 1,186,100 773,000 3,030,500 1,858,400 Other (5,119,500 ) (5,820,300 ) (13,085,600 ) (13,952,000 ) Total $ 3,602,600 $ 5,774,300 $ 10,921,300 $ 14,217,700 |
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS | 9 Months Ended |
Nov. 30, 2021 | |
Fair Value Disclosures [Abstract] | |
Fair Value Disclosures [Text Block] | Note 9 The valuation hierarchy included in GAAP considers the transparency of inputs used to value assets and liabilities as of the measurement date. A financial instrument’s classification within the valuation hierarchy is based on the lowest level of input that is significant to its fair value measurement. The three levels of the valuation hierarchy and the classification of our financial assets and liabilities within the hierarchy are as follows: Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 – Observable inputs other than quoted prices included within Level 1 for the asset or liability, either directly or indirectly. If an asset or liability has a specified term, a Level 2 input must be observable for substantially the full term of the asset or liability. Level 3 – Unobservable inputs for the asset or liability. The Company did not have any financial assets and liabilities that were required to be measured at fair value. The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and other current liabilities approximate fair value due to their short maturities. The fair value of our term notes payable is estimated by management to approximate $25,161,000 and $11,078,800 at November 30, 2021 and February 28, 2021, respectively. Management’s estimates are based on the obligations’ characteristics, including floating interest rate, maturity, and collateral. Such valuation inputs are considered a Level 2 measurement in the fair value valuation hierarchy. |
DEFERRED REVENUES
DEFERRED REVENUES | 9 Months Ended |
Nov. 30, 2021 | |
Disclosure Text Block [Abstract] | |
Deferred Revenue Disclosure [Text Block] | Note 10 The Company’s UBAM division receives payments on orders in advance of shipment. Any payments received prior to the end of the period that were not shipped as of November 30, 2021 or February 28, 2021 are recorded as deferred revenues on the condensed balance sheets. We received approximately $1,155,700 and $2,475,900, as of November 30, 2021 and February 28, 2021, respectively, in payments for sales orders which will be shipped subsequent to the end of the period. |
SUBSEQUENT EVENT
SUBSEQUENT EVENT | 9 Months Ended |
Nov. 30, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Events [Text Block] | Note 11 On December 1, 2021 the Company acquired Learning Wrap-Ups, Inc, (Learning Wrap-Ups) for an initial purchase price of $800,000, which approximates the net assets acquired by the Company. Learning Wrap-Ups historical annual sales total approximately $1.5 million. On January 5, 2022 the Board of Directors approved a $0.10 dividend that will be paid to shareholders of record on Tuesday, February 22, 2022. |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 9 Months Ended |
Nov. 30, 2021 | |
Accounting Policies [Abstract] | |
Basis of Accounting, Policy [Policy Text Block] | Basis of Presentation The accompanying Unaudited Condensed Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim condensed financial information and in accordance with the rules and regulations of the Securities and Exchange Commission. The Unaudited Condensed Financial Statements include all adjustments considered necessary for a fair presentation of the financial position and results of operations for the interim periods presented. Such adjustments consist only of normal recurring items, unless otherwise disclosed herein. Accordingly, the Unaudited Condensed Financial Statements do not include all of the information and notes required by GAAP for complete financial statements. However, we believe that the disclosures made are adequate to make the information not misleading. These interim Unaudited Condensed Financial Statements should be read in conjunction with our audited financial statements as of and for the year ended February 28, 2021 included in our Form 10-K. The results of operations for interim periods are not necessarily indicative of the results to be expected for a full year due to the seasonality of our product sales. |
Reclassification, Comparability Adjustment [Policy Text Block] | Reclassifications Certain reclassifications have been made to the fiscal 2021 condensed balance sheet, condensed statement of cash flows and footnotes to conform to the classifications used in fiscal 2022. These reclassifications had no effect on net earnings. |
Use of Estimates, Policy [Policy Text Block] | Use of Estimates in the Preparation of Financial Statements The preparation of the Unaudited Condensed Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in these financial statements and accompanying notes. Actual results could differ from those estimates. |
New Accounting Pronouncements, Policy [Policy Text Block] | New Accounting Pronouncements The Financial Accounting Standards Board (“FASB”) periodically issues new accounting standards in a continuing effort to improve standards of financial accounting and reporting. We have reviewed the recently issued accounting standards updates (“ASU”) and concluded that the following recently issued accounting standards apply to us: In December 2019, the FASB published ASU 2019-12: Income Taxes (Topic 740), which simplifies the accounting for income taxes. Topic 740 addresses a number of topics including but not limited to the removal of certain exceptions currently included in the standard related to intra-period allocation when there are losses, in addition to calculation of income taxes when current year-to-date losses exceed anticipated loss for the year. The amendment also simplifies accounting for certain franchise taxes and disclosure of the effect of enacted change in tax laws or rates. Topic 740 was adopted by the Company at the beginning of fiscal year 2022 and did not have a material impact on our financial statements and disclosures. |
INVENTORIES (Tables)
INVENTORIES (Tables) | 9 Months Ended |
Nov. 30, 2021 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventory [Table Text Block] | Inventories consist of the following: November 30, 2021 February 28, 2021 Current: Book inventory $ 69,851,400 $ 52,276,200 Inventory valuation allowance (615,200 ) (513,800 ) Inventories net – current $ 69,236,200 $ 51,762,400 Noncurrent: Book inventory $ 2,165,500 $ 894,300 Inventory valuation allowance (317,000 ) (209,000 ) Inventories net – noncurrent $ 1,848,500 $ 685,300 |
LEASES (Tables)
LEASES (Tables) | 9 Months Ended |
Nov. 30, 2021 | |
Disclosure Text Block [Abstract] | |
Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block] | Future minimum payments receivable under operating leases with terms greater than one year are estimated as follows: Years ending February 28 (29), 2022 $ 391,100 2023 1,573,200 2024 1,577,900 2025 1,547,100 2026 1,524,300 Thereafter 8,091,000 Total $ 14,704,600 |
DEBT (Tables)
DEBT (Tables) | 9 Months Ended |
Nov. 30, 2021 | |
Debt Disclosure [Abstract] | |
Schedule of Debt [Table Text Block] | Debt consists of the following: November 30, 2021 February 28, 2021 Line of credit $ 3,019,400 $ 5,245,300 Advancing term loan #1 $ 5,013,700 $ - Advancing term loan #2 10,000,000 - Term loan #1 10,514,200 10,984,700 Total long-term debt 25,527,900 10,984,700 Less current maturities (2,525,400 ) (533,500 ) Less debt issue cost (49,600 ) - Long-term debt, net $ 22,952,900 $ 10,451,200 |
Schedule of Long-term Debt Instruments [Table Text Block] | The advancing term loans and the line of credit accrue interest at a tiered rate based on our Adjusted Funded Debt to EBITDA ratio. The variable interest pricing tiers are as follows: Pricing Tier Adjusted Funded Debt to EBITDA Ratio LIBOR Margin (bps) I > 2.50 325.00 II > 2.00 but < 300.00 III > 1.50 but < 275.00 IV < 250.00 |
Schedule of Maturities of Long-term Debt [Table Text Block] | The following table reflects aggregate future scheduled maturities of long-term debt during the next five fiscal years and thereafter as follows: Years ending February 28 (29), 2022 $ 622,700 2023 2,541,800 2024 2,587,900 2025 2,634,700 2026 10,499,200 Thereafter 6,641,600 Total $ 25,527,900 |
EARNINGS PER SHARE (Tables)
EARNINGS PER SHARE (Tables) | 9 Months Ended |
Nov. 30, 2021 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] | The computation of weighted average common and common equivalent shares used in the calculation of basic and diluted EPS is shown below: Three Months Ended November 30, Nine Months Ended November 30, 2021 2020 2021 2020 Earnings: Net earnings applicable to common shareholders $ 2,646,600 $ 4,269,600 $ 7,982,900 $ 10,455,700 Weighted average shares: Weighted average shares outstanding-basic 8,029,060 8,355,831 8,028,973 8,354,156 Issued unvested restricted stock and assumed shares issuable under granted unvested restricted stock awards 401,161 - 420,210 - Weighted average shares outstanding-diluted 8,430,221 8,355,831 8,449,183 8,354,156 Earnings per share: Basic $ 0.33 $ 0.51 $ 0.99 $ 1.25 Diluted $ 0.31 $ 0.51 $ 0.94 $ 1.25 |
STOCK-BASED COMPENSATION (Table
STOCK-BASED COMPENSATION (Tables) | 9 Months Ended |
Nov. 30, 2021 | |
Share-based Payment Arrangement, Disclosure [Abstract] | |
Share-based Payment Arrangement, Cost by Plan [Table Text Block] | A summary of compensation expense recognized in connection with restricted share awards follows: Three Months Ended November 30, Nine Months Ended November 30, 2021 2020 2021 2020 Share-based compensation expense $ 261,600 $ 291,800 $ 784,900 $ 677,000 |
Nonvested Restricted Stock Shares Activity [Table Text Block] | The following table summarizes stock award activity during the first nine months of fiscal year 2022 under the 2019 LTI Plan: Shares Weighted Average Fair Value (per share) Outstanding at February 28, 2021 600,000 $ 8.14 Granted - - Vested - - Forfeited - - Outstanding at November 30, 2021 600,000 $ 8.14 |
BUSINESS SEGMENTS (Tables)
BUSINESS SEGMENTS (Tables) | 9 Months Ended |
Nov. 30, 2021 | |
Segment Reporting [Abstract] | |
Schedule of Segment Reporting Information, by Segment [Table Text Block] | Information by reporting segment for the three and nine-month periods ended November 30, 2021 and 2020, are as follows: NET REVENUES Three Months Ended November 30, Nine Months Ended November 30, 2021 2020 2021 2020 UBAM $ 41,397,800 $ 64,169,700 $ 108,532,800 $ 158,007,500 Publishing 3,714,500 2,580,600 10,381,800 6,284,600 Total $ 45,112,300 $ 66,750,300 $ 118,914,600 $ 164,292,100 EARNINGS (LOSS) BEFORE INCOME TAXES Three Months Ended November 30, Nine Months Ended November 30, 2021 2020 2021 2020 UBAM $ 7,536,000 $ 10,821,600 $ 20,976,400 $ 26,311,300 Publishing 1,186,100 773,000 3,030,500 1,858,400 Other (5,119,500 ) (5,820,300 ) (13,085,600 ) (13,952,000 ) Total $ 3,602,600 $ 5,774,300 $ 10,921,300 $ 14,217,700 |
INVENTORIES (Details)
INVENTORIES (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2021 | Nov. 30, 2020 | Feb. 28, 2021 | |
INVENTORIES (Details) [Line Items] | |||||
Other Inventory, in Transit, Gross | $ 4,204,700 | $ 4,204,700 | $ 6,467,400 | ||
Payments for Purchase of Other Assets | 15,946,700 | $ 34,973,000 | 52,511,000 | $ 53,190,200 | |
England Based Publishing Company [Member] | |||||
INVENTORIES (Details) [Line Items] | |||||
Payments for Purchase of Other Assets | $ 10,728,800 | $ 26,199,600 | $ 35,144,100 | $ 37,531,600 |
INVENTORIES (Details) - Schedu
INVENTORIES (Details) - Schedule of Inventory - USD ($) | Nov. 30, 2021 | Feb. 28, 2021 |
Inventory Current [Member] | ||
Current: | ||
Book inventory | $ 69,851,400 | $ 52,276,200 |
Inventory valuation allowance | (615,200) | (513,800) |
Inventories net | 69,236,200 | 51,762,400 |
Inventory, Noncurrent [Member] | ||
Current: | ||
Book inventory | 2,165,500 | 894,300 |
Inventory valuation allowance | (317,000) | (209,000) |
Inventories net | $ 1,848,500 | $ 685,300 |
LEASES (Details)
LEASES (Details) | 9 Months Ended | |
Nov. 30, 2021USD ($) | Feb. 28, 2021USD ($) | |
Disclosure Text Block [Abstract] | ||
Number of Rental Agreements | 3 | |
Property, Plant, and Equipment, Lessor Asset under Operating Lease, after Accumulated Depreciation | $ 10,834,300 | $ 10,826,400 |
Property, Plant, and Equipment, Lessor Asset under Operating Lease, Accumulated Depreciation | $ 2,506,600 | $ 2,216,700 |
LEASES (Details) - Lessor, Oper
LEASES (Details) - Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity | Nov. 30, 2021USD ($) |
Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Abstract] | |
2022 | $ 391,100 |
2023 | 1,573,200 |
2024 | 1,577,900 |
2025 | 1,547,100 |
2026 | 1,524,300 |
Thereafter | 8,091,000 |
Total | $ 14,704,600 |
DEBT (Details)
DEBT (Details) - USD ($) | Nov. 19, 2021 | Dec. 01, 2015 | Nov. 30, 2021 | Jul. 16, 2021 | Apr. 01, 2021 | Feb. 28, 2021 |
Line of Credit [Member] | ||||||
DEBT (Details) [Line Items] | ||||||
Line of Credit Facility, Maximum Borrowing Capacity | $ 20,000,000 | |||||
Line of Credit Facility, Expiration Date | Aug. 15, 2022 | |||||
Debt Instrument, Interest Rate, Basis for Effective Rate | interest payable monthly at the Bank-adjusted LIBOR Index plus a tiered pricing rate based on the Company’s Adjusted Funded Debt to EBITDA Ratio, with a minimum rate of 3.00% (the effective rate was 3.00% | |||||
Line of Credit Facility, Interest Rate at Period End | 3.00% | |||||
Line of Credit Facility, Remaining Borrowing Capacity | $ 16,980,600 | $ 9,570,200 | ||||
Tranche A [Member] | Notes Payable to Banks [Member] | ||||||
DEBT (Details) [Line Items] | ||||||
Line of Credit Facility, Maximum Borrowing Capacity | $ 13,400,000 | |||||
Debt Instrument, Interest Rate During Period | 4.23% | |||||
Line of Credit Facility, Expiration Date | Dec. 1, 2025 | |||||
Debt Instrument, Interest Rate, Stated Percentage | 3.12% | |||||
Term Loan # 2 [Member] | Line of Credit [Member] | ||||||
DEBT (Details) [Line Items] | ||||||
Line of Credit Facility, Maximum Borrowing Capacity | $ 20,000,000 | |||||
Advancing Term Loan [Member] | ||||||
DEBT (Details) [Line Items] | ||||||
Debt Instrument, Interest Rate During Period | 3.00% | |||||
Debt Instrument, Face Amount | $ 6,000,000 | |||||
Debt Instrument, Interest Rate Terms | The Advancing Term Loan #1 required interest-only payments through July 15, 2021, at which time it was converted to a 60-month amortizing term loan maturing July 15, 2026. The Advancing Term Loan #1 accrues interest at the Bank-adjusted LIBOR Index plus a tiered pricing rate based on the Company’s Adjusted Funded Debt to EBITDA Ratio, with a minimum rate of 3.00% | |||||
Advancing Term Loan #2 [Member] | ||||||
DEBT (Details) [Line Items] | ||||||
Debt Instrument, Interest Rate During Period | 3.00% | |||||
Debt Instrument, Face Amount | $ 10,000,000 | |||||
Debt Instrument, Interest Rate Terms | The Advancing Term Loan #2 is a 120-month amortizing loan maturing November 19, 2031 and accrues interest at the Bank-adjusted LIBOR Index plus a tiered pricing rate based on the Company’s Adjusted Funded Debt to EBITDA Ratio, with a minimum rate of 3.00% | |||||
Tranche B [Member] | Notes Payable to Banks [Member] | ||||||
DEBT (Details) [Line Items] | ||||||
Debt Instrument, Interest Rate, Basis for Effective Rate | term loans and the line of credit accrue interest at a tiered rate based on our Adjusted Funded Debt to EBITDA ratio. |
DEBT (Details) - Schedule of D
DEBT (Details) - Schedule of Debt - USD ($) | Nov. 30, 2021 | Feb. 28, 2021 |
DEBT (Details) - Schedule of Debt [Line Items] | ||
Line of credit | $ 3,019,400 | $ 5,245,300 |
Total long-term debt | 25,527,900 | 10,984,700 |
Less current maturities | (2,525,400) | (533,500) |
Less debt issue cost | (49,600) | 0 |
Long-term debt, net | 22,952,900 | 10,451,200 |
Advancing Term Loan [Member] | ||
DEBT (Details) - Schedule of Debt [Line Items] | ||
Term loan | 5,013,700 | 0 |
Advancing Term Loan #2 [Member] | ||
DEBT (Details) - Schedule of Debt [Line Items] | ||
Term loan | 10,000,000 | 0 |
Term Loan #1 [Member] | ||
DEBT (Details) - Schedule of Debt [Line Items] | ||
Term loan | $ 10,514,200 | $ 10,984,700 |
DEBT (Details) - Schedule of L
DEBT (Details) - Schedule of Long-term Debt Instruments | 9 Months Ended |
Nov. 30, 2021 | |
Pricing Tier I [Member] | |
Debt Instrument [Line Items] | |
Adjusted Funded Debt to EBITDA Ratio | > 2.50 |
Pricing Tier II [Member] | |
Debt Instrument [Line Items] | |
Adjusted Funded Debt to EBITDA Ratio | > 2.00 but < 2.50 |
Pricing Tier III [Member] | |
Debt Instrument [Line Items] | |
Adjusted Funded Debt to EBITDA Ratio | > 1.50 but < 2.00 |
Pricing Tier IV [Member] | |
Debt Instrument [Line Items] | |
Adjusted Funded Debt to EBITDA Ratio | < 1.50 |
London Interbank Offered Rate (LIBOR) [Member] | Pricing Tier I [Member] | |
Debt Instrument [Line Items] | |
LIBOR Margin | 325.00% |
London Interbank Offered Rate (LIBOR) [Member] | Pricing Tier II [Member] | |
Debt Instrument [Line Items] | |
LIBOR Margin | 300.00% |
London Interbank Offered Rate (LIBOR) [Member] | Pricing Tier III [Member] | |
Debt Instrument [Line Items] | |
LIBOR Margin | 275.00% |
London Interbank Offered Rate (LIBOR) [Member] | Pricing Tier IV [Member] | |
Debt Instrument [Line Items] | |
LIBOR Margin | 250.00% |
DEBT (Details) - Schedule of M
DEBT (Details) - Schedule of Maturities of Long-term Debt - USD ($) | Nov. 30, 2021 | Feb. 28, 2021 |
Schedule of Maturities of Long-term Debt [Abstract] | ||
2022 | $ 622,700 | |
2023 | 2,541,800 | |
2024 | 2,587,900 | |
2025 | 2,634,700 | |
2026 | 10,499,200 | |
Thereafter | 6,641,600 | |
Total | $ 25,527,900 | $ 10,984,700 |
EARNINGS PER SHARE (Details) -
EARNINGS PER SHARE (Details) - Schedule of Earnings Per Share, Basic and Diluted - USD ($) | 3 Months Ended | 9 Months Ended | ||
Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2021 | Nov. 30, 2020 | |
Earnings: | ||||
Net earnings applicable to common shareholders (in Dollars) | $ 2,646,600 | $ 4,269,600 | $ 7,982,900 | $ 10,455,700 |
Weighted average shares: | ||||
Weighted average shares outstanding-basic | 8,029,060 | 8,355,831 | 8,028,973 | 8,354,156 |
Issued unvested restricted stock and assumed shares issuable under granted unvested restricted stock awards | 401,161 | 0 | 420,210 | 0 |
Weighted average shares outstanding-diluted | 8,430,221 | 8,355,831 | 8,449,183 | 8,354,156 |
Earnings per share: | ||||
Basic (in Dollars per share) | $ 0.33 | $ 0.51 | $ 0.99 | $ 1.25 |
Diluted (in Dollars per share) | $ 0.31 | $ 0.51 | $ 0.94 | $ 1.25 |
STOCK-BASED COMPENSATION (Detai
STOCK-BASED COMPENSATION (Details) - USD ($) | 9 Months Ended | 12 Months Ended | ||
Nov. 30, 2021 | Feb. 28, 2021 | Feb. 28, 2019 | Jul. 31, 2021 | |
STOCK-BASED COMPENSATION (Details) [Line Items] | ||||
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition | 29 months 18 days | |||
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount (in Dollars) | $ 2,093,500 | |||
The 2019 Long-term Incentive Plan [Member] | ||||
STOCK-BASED COMPENSATION (Details) [Line Items] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Description | The 2019 LTI Plan established up to 600,000 shares of restricted stock available to be granted to certain members of management based on exceeding specified net revenues and pre-tax performance metrics during fiscal years 2019, 2020 or 2021. The Company exceeded all defined metrics during these fiscal years and 600,000 shares were granted to members of management according to the Plan. The granted shares under the 2019 LTI Plan “cliff vest” after five years from the fiscal year that the defined metrics were exceeded.In July 2021, our shareholders approved the Company’s 2022 Long-Term Incentive Plan (“2022 LTI Plan”). The 2022 LTI Plan establishes up to 300,000 shares of restricted stock available to be granted to certain members of management based on exceeding specified net revenues and pre-tax performance metrics during fiscal years 2022 and 2023. The number of restricted shares to be distributed depends on attaining the performance metrics defined by the 2022 LTI Plan and may result in the distribution of a number of shares that is less than, but not greater than, the number of restricted shares outlined in the terms of the 2022 LTI Plan. | |||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 600,000 | |||
Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture | 600,000 | 297,000 | 308,000 | |
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 5 years | |||
Shares Issued, Price Per Share (in Dollars per share) | $ 6.3 | $ 9.94 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares | 5,000 | 5,000 | ||
Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount (in Dollars) | $ 1,276,600 | $ 816,900 | ||
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition | 39 months | 15 months | ||
2022 Long-Term Incentive Plan [Member] | ||||
STOCK-BASED COMPENSATION (Details) [Line Items] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 300,000 |
STOCK-BASED COMPENSATION (Det_2
STOCK-BASED COMPENSATION (Details) - Share-based Payment Arrangement, Cost by Plan - USD ($) | 3 Months Ended | 9 Months Ended | ||
Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2021 | Nov. 30, 2020 | |
Share-based Payment Arrangement, Cost by Plan [Abstract] | ||||
Share-based compensation expense | $ 261,600 | $ 291,800 | $ 784,900 | $ 677,000 |
STOCK-BASED COMPENSATION (Det_3
STOCK-BASED COMPENSATION (Details) - Nonvested Restricted Stock Shares Activity | 9 Months Ended |
Nov. 30, 2021$ / sharesshares | |
Nonvested Restricted Stock Shares Activity [Abstract] | |
Outstanding, Shares | shares | 600,000 |
Outstanding, Weighted Average Fair Value | $ / shares | $ 8.14 |
Vested, Shares | shares | 0 |
Vested, Weighted Average Fair Value | $ / shares | $ 0 |
Outstanding, Shares | shares | 600,000 |
Outstanding, Weighted Average Fair Value | $ / shares | $ 8.14 |
SHIPPING AND HANDLING COSTS (De
SHIPPING AND HANDLING COSTS (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2021 | Nov. 30, 2020 | |
Shipping and Handling [Member] | ||||
SHIPPING AND HANDLING COSTS (Details) [Line Items] | ||||
Cost of Goods and Services Sold | $ 6,924,800 | $ 10,610,900 | $ 18,317,200 | $ 26,910,800 |
BUSINESS SEGMENTS (Details)
BUSINESS SEGMENTS (Details) | 9 Months Ended |
Nov. 30, 2021 | |
Segment Reporting [Abstract] | |
Number of Reportable Segments | 2 |
BUSINESS SEGMENTS (Details) -
BUSINESS SEGMENTS (Details) - Schedule of Information by Industry Segment - USD ($) | 3 Months Ended | 9 Months Ended | ||
Nov. 30, 2021 | Nov. 30, 2020 | Nov. 30, 2021 | Nov. 30, 2020 | |
Segment Reporting Information [Line Items] | ||||
Net Revenues | $ 45,112,300 | $ 66,750,300 | $ 118,914,600 | $ 164,292,100 |
Earnings (Loss) Before Income Taxes | 3,602,600 | 5,774,300 | 10,921,300 | 14,217,700 |
Usborne Books and More [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Net Revenues | 41,397,800 | 64,169,700 | 108,532,800 | 158,007,500 |
Earnings (Loss) Before Income Taxes | 7,536,000 | 10,821,600 | 20,976,400 | 26,311,300 |
Publishing [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Net Revenues | 3,714,500 | 2,580,600 | 10,381,800 | 6,284,600 |
Earnings (Loss) Before Income Taxes | 1,186,100 | 773,000 | 3,030,500 | 1,858,400 |
Other Segments [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Earnings (Loss) Before Income Taxes | $ (5,119,500) | $ (5,820,300) | $ (13,085,600) | $ (13,952,000) |
FAIR VALUE MEASUREMENTS (Detail
FAIR VALUE MEASUREMENTS (Details) - USD ($) | Nov. 30, 2021 | Feb. 28, 2021 |
Fair Value, Inputs, Level 2 [Member] | ||
FAIR VALUE MEASUREMENTS (Details) [Line Items] | ||
Long-term Debt, Fair Value | $ 25,161,000 | $ 11,078,800 |
DEFERRED REVENUES (Details)
DEFERRED REVENUES (Details) - USD ($) | 9 Months Ended | 12 Months Ended |
Nov. 30, 2021 | Feb. 28, 2021 | |
Disclosure Text Block [Abstract] | ||
Deferred Revenue, Additions | $ 1,155,700 | $ 2,475,900 |
SUBSEQUENT EVENT (Details)
SUBSEQUENT EVENT (Details) - Subsequent Event [Member] - USD ($) $ / shares in Units, $ in Millions | Jan. 05, 2022 | Dec. 01, 2021 |
SUBSEQUENT EVENT (Details) [Line Items] | ||
Dividends Payable, Date Declared | Jan. 5, 2022 | |
Common Stock, Dividends, Per Share, Declared | $ 0.1 | |
Dividends Payable, Date of Record | Feb. 22, 2022 | |
Learning Wrap-Ups [Member] | ||
SUBSEQUENT EVENT (Details) [Line Items] | ||
Business Acquisition, Revenue Reported by Acquired Entity for Last Annual Period | $ 1.5 |